Structure

Physi-Chem Properties

Molecular Weight:  562.25
Volume:  579.771
LogP:  6.625
LogD:  3.863
LogS:  -7.269
# Rotatable Bonds:  2
TPSA:  72.42
# H-Bond Aceptor:  7
# H-Bond Donor:  2
# Rings:  8
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.255
Synthetic Accessibility Score:  5.833
Fsp3:  0.314
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.719
MDCK Permeability:  1.739984145388007e-05
Pgp-inhibitor:  0.993
Pgp-substrate:  0.972
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.912
30% Bioavailability (F30%):  0.962

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.054
Plasma Protein Binding (PPB):  58.11567687988281%
Volume Distribution (VD):  1.089
Pgp-substrate:  18.063030242919922%

ADMET: Metabolism

CYP1A2-inhibitor:  0.116
CYP1A2-substrate:  0.951
CYP2C19-inhibitor:  0.184
CYP2C19-substrate:  0.913
CYP2C9-inhibitor:  0.048
CYP2C9-substrate:  0.535
CYP2D6-inhibitor:  0.026
CYP2D6-substrate:  0.957
CYP3A4-inhibitor:  0.086
CYP3A4-substrate:  0.944

ADMET: Excretion

Clearance (CL):  7.724
Half-life (T1/2):  0.114

ADMET: Toxicity

hERG Blockers:  0.953
Human Hepatotoxicity (H-HT):  0.046
Drug-inuced Liver Injury (DILI):  0.561
AMES Toxicity:  0.15
Rat Oral Acute Toxicity:  0.411
Maximum Recommended Daily Dose:  0.997
Skin Sensitization:  0.791
Carcinogencity:  0.042
Eye Corrosion:  0.003
Eye Irritation:  0.004
Respiratory Toxicity:  0.488

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC256124

Natural Product ID:  NPC256124
Common Name*:   DOUULZLWVARYRD-SVBPBHIXSA-N
IUPAC Name:   n.a.
Synonyms:   2'-Nortiliacorinine
Standard InCHIKey:  DOUULZLWVARYRD-SVBPBHIXSA-N
Standard InCHI:  InChI=1S/C35H34N2O5/c1-37-11-9-22-17-32(40-3)34-35-33(22)27(37)15-20-5-7-29(39-2)25(13-20)24-12-19(4-6-28(24)38)14-26-23-18-31(42-35)30(41-34)16-21(23)8-10-36-26/h4-7,12-13,16-18,26-27,36,38H,8-11,14-15H2,1-3H3/t26-,27-/m0/s1
SMILES:  CN1CCc2cc(c3c4c2[C@@H]1Cc1ccc(c(-c2cc(ccc2O)C[C@H]2c5cc(c(cc5CCN2)O3)O4)c1)OC)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2017490
PubChem CID:   14527219
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO941 Tiliacora triandra Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[22418278]
NPO941 Tiliacora triandra Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT171 Cell Line MRC5 Homo sapiens IC50 = 3.8 ug.mL-1 PMID[448455]
NPT115 Organism Mycobacterium tuberculosis H37Ra Mycobacterium tuberculosis H37Ra MIC = 3.1 ug.mL-1 PMID[448455]
NPT790 Organism Mycobacterium tuberculosis H37Rv Mycobacterium tuberculosis H37Rv MIC = 3.1 ug.mL-1 PMID[448455]
NPT790 Organism Mycobacterium tuberculosis H37Rv Mycobacterium tuberculosis H37Rv MIC = 6.2 ug.mL-1 PMID[448455]
NPT790 Organism Mycobacterium tuberculosis H37Rv Mycobacterium tuberculosis H37Rv MIC = 1.5 ug.mL-1 PMID[448455]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC256124 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9709 High Similarity NPC65312
0.9709 High Similarity NPC139783
0.9655 High Similarity NPC191132
0.9655 High Similarity NPC60295
0.9651 High Similarity NPC16357
0.9651 High Similarity NPC95426
0.9651 High Similarity NPC302245
0.9598 High Similarity NPC175890
0.9598 High Similarity NPC48490
0.9598 High Similarity NPC274661
0.9598 High Similarity NPC82457
0.9598 High Similarity NPC11296
0.954 High Similarity NPC275680
0.954 High Similarity NPC22115
0.9477 High Similarity NPC239584
0.9419 High Similarity NPC475479
0.9419 High Similarity NPC243454
0.9368 High Similarity NPC167116
0.9368 High Similarity NPC254441
0.9368 High Similarity NPC274716
0.931 High Similarity NPC42663
0.931 High Similarity NPC290582
0.931 High Similarity NPC222661
0.931 High Similarity NPC285931
0.931 High Similarity NPC258657
0.931 High Similarity NPC229373
0.931 High Similarity NPC311973
0.931 High Similarity NPC251735
0.931 High Similarity NPC49075
0.931 High Similarity NPC328155
0.931 High Similarity NPC15414
0.931 High Similarity NPC290005
0.931 High Similarity NPC54654
0.931 High Similarity NPC185639
0.931 High Similarity NPC7715
0.931 High Similarity NPC90998
0.931 High Similarity NPC104196
0.931 High Similarity NPC8836
0.931 High Similarity NPC181796
0.931 High Similarity NPC182052
0.931 High Similarity NPC223690
0.931 High Similarity NPC271013
0.931 High Similarity NPC217748
0.931 High Similarity NPC239824
0.931 High Similarity NPC279228
0.9266 High Similarity NPC206900
0.9261 High Similarity NPC212237
0.9261 High Similarity NPC116465
0.9253 High Similarity NPC286119
0.92 High Similarity NPC30779
0.9186 High Similarity NPC251580
0.9186 High Similarity NPC12424
0.9186 High Similarity NPC129518
0.9186 High Similarity NPC41376
0.9162 High Similarity NPC478093
0.9128 High Similarity NPC63646
0.9128 High Similarity NPC115284
0.9128 High Similarity NPC276890
0.9128 High Similarity NPC76682
0.9128 High Similarity NPC227060
0.9128 High Similarity NPC10908
0.9128 High Similarity NPC317145
0.9128 High Similarity NPC198498
0.9128 High Similarity NPC317439
0.9111 High Similarity NPC478091
0.9111 High Similarity NPC473589
0.9111 High Similarity NPC30182
0.9111 High Similarity NPC478092
0.908 High Similarity NPC293093
0.905 High Similarity NPC281581
0.9034 High Similarity NPC230276
0.9034 High Similarity NPC257269
0.9027 High Similarity NPC254581
0.8977 High Similarity NPC40496
0.8977 High Similarity NPC119068
0.895 High Similarity NPC24260
0.8933 High Similarity NPC302275
0.8908 High Similarity NPC475215
0.8908 High Similarity NPC108434
0.8833 High Similarity NPC47077
0.8833 High Similarity NPC14507
0.8779 High Similarity NPC475393
0.8771 High Similarity NPC73492
0.8771 High Similarity NPC299990
0.8764 High Similarity NPC474507
0.8696 High Similarity NPC85381
0.8689 High Similarity NPC41122
0.8689 High Similarity NPC318805
0.8678 High Similarity NPC317272
0.8678 High Similarity NPC13916
0.8678 High Similarity NPC256012
0.8678 High Similarity NPC250846
0.8678 High Similarity NPC223077
0.8678 High Similarity NPC193853
0.8678 High Similarity NPC264850
0.8678 High Similarity NPC42549
0.8678 High Similarity NPC56887
0.8678 High Similarity NPC268503
0.8678 High Similarity NPC240841
0.8663 High Similarity NPC475654
0.8652 High Similarity NPC173416
0.8652 High Similarity NPC148709
0.8652 High Similarity NPC476577
0.8621 High Similarity NPC24465
0.8621 High Similarity NPC209377
0.8602 High Similarity NPC234318
0.858 High Similarity NPC83198
0.858 High Similarity NPC204908
0.8571 High Similarity NPC249996
0.8541 High Similarity NPC476565
0.8539 High Similarity NPC192135
0.8539 High Similarity NPC190783
0.8539 High Similarity NPC66341
0.8539 High Similarity NPC232386
0.8539 High Similarity NPC152680
0.8539 High Similarity NPC477020
0.8531 High Similarity NPC109925
0.8525 High Similarity NPC57036
0.8523 High Similarity NPC204947
0.852 High Similarity NPC38964
0.8508 High Similarity NPC195538
0.8506 High Similarity NPC79402
0.8506 High Similarity NPC80759
0.8488 Intermediate Similarity NPC247639
0.8488 Intermediate Similarity NPC25084
0.8486 Intermediate Similarity NPC473716
0.8486 Intermediate Similarity NPC259350
0.8486 Intermediate Similarity NPC223236
0.8486 Intermediate Similarity NPC475597
0.8483 Intermediate Similarity NPC239775
0.8466 Intermediate Similarity NPC195392
0.8462 Intermediate Similarity NPC476202
0.8448 Intermediate Similarity NPC205255
0.8448 Intermediate Similarity NPC271388
0.8448 Intermediate Similarity NPC235143
0.8448 Intermediate Similarity NPC119649
0.8448 Intermediate Similarity NPC230956
0.8427 Intermediate Similarity NPC118274
0.8427 Intermediate Similarity NPC69712
0.8427 Intermediate Similarity NPC26240
0.8427 Intermediate Similarity NPC477562
0.8427 Intermediate Similarity NPC168753
0.8409 Intermediate Similarity NPC121275
0.8409 Intermediate Similarity NPC4138
0.8409 Intermediate Similarity NPC284183
0.8391 Intermediate Similarity NPC7393
0.8391 Intermediate Similarity NPC221864
0.8387 Intermediate Similarity NPC475754
0.8378 Intermediate Similarity NPC186546
0.8378 Intermediate Similarity NPC476576
0.8342 Intermediate Similarity NPC82056
0.8333 Intermediate Similarity NPC79328
0.8315 Intermediate Similarity NPC306555
0.8315 Intermediate Similarity NPC145832
0.8315 Intermediate Similarity NPC474931
0.8315 Intermediate Similarity NPC81218
0.8315 Intermediate Similarity NPC158376
0.8315 Intermediate Similarity NPC12053
0.8315 Intermediate Similarity NPC117188
0.8315 Intermediate Similarity NPC205421
0.8306 Intermediate Similarity NPC32413
0.8306 Intermediate Similarity NPC474506
0.8295 Intermediate Similarity NPC60186
0.8278 Intermediate Similarity NPC10871
0.8276 Intermediate Similarity NPC29647
0.8258 Intermediate Similarity NPC81247
0.8258 Intermediate Similarity NPC476573
0.8258 Intermediate Similarity NPC35627
0.8251 Intermediate Similarity NPC470879
0.8251 Intermediate Similarity NPC258695
0.8242 Intermediate Similarity NPC241704
0.8218 Intermediate Similarity NPC189266
0.8218 Intermediate Similarity NPC54379
0.8218 Intermediate Similarity NPC2413
0.8218 Intermediate Similarity NPC187022
0.8218 Intermediate Similarity NPC207757
0.8218 Intermediate Similarity NPC204828
0.8218 Intermediate Similarity NPC193949
0.8218 Intermediate Similarity NPC249797
0.8218 Intermediate Similarity NPC184026
0.8218 Intermediate Similarity NPC295691
0.8218 Intermediate Similarity NPC469817
0.8218 Intermediate Similarity NPC123323
0.8218 Intermediate Similarity NPC110416
0.8218 Intermediate Similarity NPC80129
0.8218 Intermediate Similarity NPC276588
0.8218 Intermediate Similarity NPC278799
0.8218 Intermediate Similarity NPC5238
0.8218 Intermediate Similarity NPC127674
0.8218 Intermediate Similarity NPC39701
0.8218 Intermediate Similarity NPC172765
0.8216 Intermediate Similarity NPC135772
0.8202 Intermediate Similarity NPC96603
0.8202 Intermediate Similarity NPC13504
0.8202 Intermediate Similarity NPC136508
0.8202 Intermediate Similarity NPC477563
0.8202 Intermediate Similarity NPC78222
0.8202 Intermediate Similarity NPC253043
0.8202 Intermediate Similarity NPC196447
0.8202 Intermediate Similarity NPC306843

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC256124 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.931 High Similarity NPD8053 Approved
0.931 High Similarity NPD8054 Approved
0.9128 High Similarity NPD8099 Discontinued
0.9128 High Similarity NPD8251 Approved
0.9128 High Similarity NPD8252 Approved
0.9075 High Similarity NPD8156 Discontinued
0.8977 High Similarity NPD8453 Clinical (unspecified phase)
0.822 Intermediate Similarity NPD8095 Phase 1
0.8218 Intermediate Similarity NPD7298 Approved
0.8023 Intermediate Similarity NPD4584 Approved
0.7978 Intermediate Similarity NPD6788 Approved
0.7842 Intermediate Similarity NPD7906 Approved
0.7816 Intermediate Similarity NPD1424 Approved
0.7778 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7753 Intermediate Similarity NPD4772 Phase 2
0.7753 Intermediate Similarity NPD4773 Phase 2
0.7735 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7735 Intermediate Similarity NPD7831 Phase 2
0.7735 Intermediate Similarity NPD7833 Phase 2
0.7727 Intermediate Similarity NPD6030 Approved
0.7727 Intermediate Similarity NPD6031 Approved
0.7701 Intermediate Similarity NPD3845 Phase 1
0.7692 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD4664 Clinical (unspecified phase)
0.7663 Intermediate Similarity NPD6071 Discontinued
0.7657 Intermediate Similarity NPD7598 Phase 2
0.7632 Intermediate Similarity NPD7312 Approved
0.7632 Intermediate Similarity NPD7310 Approved
0.7632 Intermediate Similarity NPD7313 Approved
0.7632 Intermediate Similarity NPD7311 Approved
0.7592 Intermediate Similarity NPD7309 Approved
0.7568 Intermediate Similarity NPD3051 Approved
0.7553 Intermediate Similarity NPD6042 Phase 2
0.7553 Intermediate Similarity NPD42 Phase 2
0.7542 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7539 Intermediate Similarity NPD4577 Approved
0.7539 Intermediate Similarity NPD4578 Approved
0.7534 Intermediate Similarity NPD8152 Approved
0.7534 Intermediate Similarity NPD8153 Approved
0.7527 Intermediate Similarity NPD2969 Approved
0.7527 Intermediate Similarity NPD2970 Approved
0.7514 Intermediate Similarity NPD6107 Approved
0.7514 Intermediate Similarity NPD7447 Phase 1
0.7513 Intermediate Similarity NPD4663 Approved
0.7487 Intermediate Similarity NPD2489 Approved
0.7487 Intermediate Similarity NPD7549 Discontinued
0.7487 Intermediate Similarity NPD27 Approved
0.7459 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD2560 Approved
0.7432 Intermediate Similarity NPD2563 Approved
0.7371 Intermediate Similarity NPD7045 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD2421 Approved
0.736 Intermediate Similarity NPD7213 Phase 3
0.736 Intermediate Similarity NPD2420 Approved
0.736 Intermediate Similarity NPD7212 Phase 2
0.7351 Intermediate Similarity NPD4055 Discovery
0.7345 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD6853 Approved
0.732 Intermediate Similarity NPD6851 Approved
0.7318 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD4678 Approved
0.7308 Intermediate Similarity NPD4675 Approved
0.7303 Intermediate Similarity NPD2422 Clinical (unspecified phase)
0.7302 Intermediate Similarity NPD2898 Approved
0.7299 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD6297 Approved
0.7273 Intermediate Similarity NPD5677 Discontinued
0.7268 Intermediate Similarity NPD6072 Discontinued
0.7257 Intermediate Similarity NPD1632 Clinical (unspecified phase)
0.724 Intermediate Similarity NPD7479 Phase 2
0.7238 Intermediate Similarity NPD5976 Discontinued
0.7232 Intermediate Similarity NPD3060 Approved
0.7228 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD7827 Phase 1
0.7219 Intermediate Similarity NPD5709 Phase 3
0.7211 Intermediate Similarity NPD4481 Phase 3
0.7207 Intermediate Similarity NPD7124 Phase 2
0.7196 Intermediate Similarity NPD4010 Discontinued
0.7189 Intermediate Similarity NPD4585 Approved
0.7182 Intermediate Similarity NPD6090 Discontinued
0.7181 Intermediate Similarity NPD4666 Phase 3
0.7158 Intermediate Similarity NPD4017 Approved
0.7158 Intermediate Similarity NPD6523 Clinical (unspecified phase)
0.7157 Intermediate Similarity NPD3452 Approved
0.7157 Intermediate Similarity NPD3450 Approved
0.7157 Intermediate Similarity NPD2494 Approved
0.7157 Intermediate Similarity NPD2493 Approved
0.7151 Intermediate Similarity NPD5241 Discontinued
0.7151 Intermediate Similarity NPD2677 Approved
0.7143 Intermediate Similarity NPD3640 Phase 3
0.7143 Intermediate Similarity NPD3639 Approved
0.7143 Intermediate Similarity NPD3641 Approved
0.7143 Intermediate Similarity NPD2122 Discontinued
0.7143 Intermediate Similarity NPD7802 Discontinued
0.7135 Intermediate Similarity NPD4162 Approved
0.7129 Intermediate Similarity NPD2975 Approved
0.7129 Intermediate Similarity NPD2974 Approved
0.7129 Intermediate Similarity NPD2973 Approved
0.7127 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD4475 Approved
0.711 Intermediate Similarity NPD4474 Approved
0.7108 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD4166 Phase 2
0.7098 Intermediate Similarity NPD4873 Discontinued
0.7097 Intermediate Similarity NPD2977 Approved
0.7097 Intermediate Similarity NPD5773 Approved
0.7097 Intermediate Similarity NPD5772 Approved
0.7097 Intermediate Similarity NPD2978 Approved
0.7097 Intermediate Similarity NPD7046 Clinical (unspecified phase)
0.7088 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7088 Intermediate Similarity NPD3647 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD6997 Phase 2
0.7074 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD4005 Discontinued
0.7059 Intermediate Similarity NPD3837 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD5160 Discontinued
0.7053 Intermediate Similarity NPD4583 Approved
0.7053 Intermediate Similarity NPD4582 Approved
0.705 Intermediate Similarity NPD2488 Approved
0.705 Intermediate Similarity NPD2490 Approved
0.7047 Intermediate Similarity NPD5940 Clinical (unspecified phase)
0.7043 Intermediate Similarity NPD3384 Approved
0.7043 Intermediate Similarity NPD3383 Approved
0.7043 Intermediate Similarity NPD3382 Approved
0.7043 Intermediate Similarity NPD5722 Discontinued
0.7042 Intermediate Similarity NPD7047 Phase 3
0.7039 Intermediate Similarity NPD5177 Phase 3
0.7039 Intermediate Similarity NPD5005 Approved
0.7039 Intermediate Similarity NPD5006 Approved
0.7033 Intermediate Similarity NPD4123 Phase 3
0.7024 Intermediate Similarity NPD4580 Approved
0.7022 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD4002 Approved
0.7005 Intermediate Similarity NPD4004 Approved
0.7 Intermediate Similarity NPD3977 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6748 Discontinued
0.6995 Remote Similarity NPD52 Approved
0.6995 Remote Similarity NPD7526 Approved
0.6995 Remote Similarity NPD7527 Clinical (unspecified phase)
0.6978 Remote Similarity NPD1774 Approved
0.6978 Remote Similarity NPD3124 Discontinued
0.6978 Remote Similarity NPD6087 Phase 1
0.6971 Remote Similarity NPD4040 Phase 1
0.697 Remote Similarity NPD6618 Phase 2
0.697 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6961 Remote Similarity NPD6284 Clinical (unspecified phase)
0.6959 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6959 Remote Similarity NPD7493 Clinical (unspecified phase)
0.6954 Remote Similarity NPD5718 Phase 2
0.6954 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6951 Remote Similarity NPD6723 Discontinued
0.6949 Remote Similarity NPD2200 Suspended
0.6939 Remote Similarity NPD6996 Clinical (unspecified phase)
0.6936 Remote Similarity NPD5752 Clinical (unspecified phase)
0.6934 Remote Similarity NPD7783 Phase 2
0.6934 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6923 Remote Similarity NPD5312 Approved
0.6923 Remote Similarity NPD6666 Approved
0.6923 Remote Similarity NPD5313 Approved
0.6923 Remote Similarity NPD6667 Approved
0.6919 Remote Similarity NPD2971 Approved
0.6919 Remote Similarity NPD2968 Approved
0.6919 Remote Similarity NPD3686 Approved
0.6919 Remote Similarity NPD3687 Approved
0.6915 Remote Similarity NPD2845 Phase 2
0.6915 Remote Similarity NPD2843 Phase 2
0.691 Remote Similarity NPD2156 Approved
0.691 Remote Similarity NPD2154 Approved
0.691 Remote Similarity NPD2155 Approved
0.6906 Remote Similarity NPD7466 Approved
0.6904 Remote Similarity NPD7039 Approved
0.6904 Remote Similarity NPD7038 Approved
0.6893 Remote Similarity NPD2568 Approved
0.6889 Remote Similarity NPD7153 Discontinued
0.6884 Remote Similarity NPD8149 Discontinued
0.6882 Remote Similarity NPD8158 Clinical (unspecified phase)
0.6878 Remote Similarity NPD6621 Clinical (unspecified phase)
0.6869 Remote Similarity NPD7132 Clinical (unspecified phase)
0.6868 Remote Similarity NPD3692 Discontinued
0.6866 Remote Similarity NPD8318 Clinical (unspecified phase)
0.6862 Remote Similarity NPD7945 Clinical (unspecified phase)
0.6862 Remote Similarity NPD5720 Discontinued
0.6854 Remote Similarity NPD7718 Clinical (unspecified phase)
0.685 Remote Similarity NPD5087 Clinical (unspecified phase)
0.6848 Remote Similarity NPD7020 Approved
0.6848 Remote Similarity NPD7019 Approved
0.6845 Remote Similarity NPD4420 Approved
0.6842 Remote Similarity NPD7773 Phase 2
0.6839 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6839 Remote Similarity NPD4908 Phase 1
0.6831 Remote Similarity NPD3122 Phase 3
0.6821 Remote Similarity NPD5602 Clinical (unspecified phase)
0.6804 Remote Similarity NPD8051 Clinical (unspecified phase)
0.68 Remote Similarity NPD6494 Phase 2
0.68 Remote Similarity NPD7922 Phase 1
0.68 Remote Similarity NPD4625 Phase 3
0.6798 Remote Similarity NPD5525 Clinical (unspecified phase)
0.6798 Remote Similarity NPD3052 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data